Donate

Category: Uncategorised

At the beginning of this week, the UK government announced plans to give GPs more authority by enabling them to make direct referrals for diagnostic tests related to a range of complaints including breathlessness – a key symptom of PH.

The move, which is part of the government’s wider bid to tackle NHS waiting lists, aims to speed up - where appropriate - access to tests by allowing patients to receive them without having to see a specialist consultant first.

Whilst full details are yet to emerge, it was announced as part of plans which also include expanding the network of diagnostic centres and surgical hubs in communities, and giving patients more choice around appointments.

PHA UK Chair Dr Iain Armstrong said:

“We welcome the news that GPs will be able to make direct referrals for diagnostic tests for those experiencing breathlessness, but in this disease area, being referred for the right tests is what will make the difference.

Breathlessness is a symptom of multiple conditions, and too many people with pulmonary arterial hypertension (PAH) are often misdiagnosed with asthma, delaying access to vital treatment. If the correct tests - such as echocardiogram - are carried out and interpreted quickly and expertly, it is this which will help reduce the time to diagnosis.

Delayed diagnosis of this life-limiting condition is a huge problem, with people waiting just as long now as they were 15 years ago. Our latest research showed 32% of patients had to see four or more doctors before receiving their diagnosis, and for 51%, it took over a year to be diagnosed after first noticing symptoms. For 24%, it took over three years, and these concerning statistics have not changed for a decade-and-a-half.  

Earlier diagnosis of pulmonary hypertension means patients get quicker access to treatment, prolonging lives and reducing the huge burden of symptoms that come with this disease. It’s clear that something needs to change, and we hope this move to allow GPs to make direct referrals first will make a difference.

However, whilst the move is welcomed, it’s important that further support is given to general practice to ensure the timeliness and accuracy of such referrals. With lengthy waits for appointments, access to GPs is also a key consideration in this - alongside the need for referrals to the correct tests.”

  • What do you think? Share your thoughts by emailing media@phauk.org and you might see your words published online or in our member magazine.

COMMENT: Move to enable GPs to make direct referrals for diagnostic tests

At the beginning of this week, the UK government announced plans to give GPs more authority by enabling them to make direct referrals for diagnostic tests related to a range of complaints including breathlessness – a key symptom of PH.

7 January 2025

MHRA approval for sotatercept

The new PAH treatment sotatercept has now been approved for use in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA).

2 January 2025

Corporate supporter spotlight: Lucideon

International materials technology business Lucideon has made generous donations to our organisation, as part of a charity partnership with its director’s car club.

29 December 2024

New self-help programme to manage depression with PH

The world's first self-help programme specifically for people with PH who struggle with depression or low mood is now available from our charity.

8 December 2024

An update on the ongoing Flolan supply issues

For the last few months, we’ve been working in collaboration with the specialist centres, homecare delivery companies, and drug manufacturers GSK to bring you regular updates on supply issues related to Flolan – which is also called epoprostenol. Following an update on 3rd December 2024, we can now confirm that there are full, safe stock […]

4 December 2024

A valuable meeting of minds

PH researchers from around the UK gathered on 1st November to share study findings, learn from each other’s work, and look to the future together…

12 November 2024